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bjectives The aim of this study was to investigate the effect of complete, incomplete, and unsuc-
essful revascularization by percutaneous coronary intervention (PCI) on left ventricular ejection frac-
ion (EF) in patients with multivessel disease and impaired left ventricular function and assess the
iagnostic accuracy of cardiac magnetic resonance imaging (MRI) for improvement in EF.
ackground The effect of PCI for multivessel coronary artery disease on long-term myocardial func-
ion and the predictive value of cardiac MRI on global function are incompletely investigated.
ethods Cardiac MRI was performed in patients with multivessel disease before and 6 months after
omplete revascularization (n  34) or incomplete revascularization (n  22) or in patients without
uccessful revascularization (n  15). For the prediction of recovery of EF, wall thickening was quan-
iﬁed on cine images at rest and during 5- and 10-g/kg/min dobutamine. The transmural extent of
nfarction was quantiﬁed on delayed enhancement cardiac MRI.
esults The EF improved signiﬁcantly after complete revascularization (46  12% to 51  13%;
 0.0001) but did not change after incomplete (49  11% to 49  10%; p  0.88) or unsuccess-
ul revascularization (49  13% to 47  13%; p  0.11). Sensitivity, speciﬁcity, positive and negative
redictive value for the prediction of improvement in EF of 4% after PCI were 100%, 75%, 74%,
nd 100%, respectively, for dobutamine-cardiac MRI and 70%, 77%, 70%, and 77%, respectively, for
elayed enhancement-cardiac MRI.
onclusions Complete revascularization for multivessel coronary artery disease improves EF,
hereas EF did not change in patients after incomplete or unsuccessful revascularization. Improve-
ent in EF can be predicted by performing cardiac MRI before PCI. (J Am Coll Cardiol Intv
010;3:392–400) © 2010 by the American College of Cardiology Foundation
rom the Departments of *Cardiology and †Radiology, Erasmus Medical Center, Rotterdam, the Netherlands.anuscript received September 28, 2009; revised manuscript received January 4, 2010, accepted January 8, 2010.
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393oronary atherosclerosis is the most common cause of heart
ailure in the western world (1). Several studies have shown
hat a coronary artery bypass graft (CABG) for multivessel
oronary atherosclerosis improved ejection fraction (EF) in the
resence of viable tissue (2–4). Nowadays, percutaneous cor-
nary intervention (PCI) is increasingly used as a revascular-
zation strategy instead of CABG, because both therapies have
he same outcome in terms of survival and rates of myocardial
nfarction, as long as the extent of disease is not too extensive
Syntax score 33) (5). Percutaneous coronary intervention
ight result in incomplete revascularization due to extensive
isease or when the vessel is not attempted in patients with
egional systolic dysfunction which is thought to be irrevers-
ble. Incomplete revascularization has a lower event free sur-
ival than complete revascularization (6,7). Most events are due
o repeated interventions, but also a lower survival rate is
ssociated with incomplete revascularization, which is not fully
nderstood. We hypothesized that complete revascularization
n patients with multivessel disease and depressed EF better
mproves EF as compared with incomplete revascularization.
See page 401
In this study we evaluated the effect of complete, incom-
lete, or unsuccessful revascularization by PCI on EF in
atients with multivessel coronary artery disease and LV
ysfunction and whether improvement in EF after success-
ul PCI can be predicted by performing cardiac magnetic
esonance imaging (MRI) before PCI.
ethods
atient population. Patients with multivessel coronary ar-
ery disease and LV wall motion abnormalities who were
eferred for PCI—on the basis of the discretion of the
hysician using the information of patient history, risk
actors, and additional noninvasive stress testing if per-
ormed–were prospectively approached for enrolment in this
tudy. Inclusion criteria were: 1) significant stenosis in at
east 2 vessels; 2) sinus rhythm; and 3) abnormalities in wall
otion on contrast ventriculography or echocardiography.
xclusion criteria were: 1) myocardial infarction within the
ast 3 months; 2) atrial fibrillation; 3) contraindications for
agnetic resonance studies; 4) inability to give reliable
nformed consent; 5) known allergy to gadolinium-based
ontrast material; and 6) unstable coronary artery disease.
The institutional review board of the Erasmus Medical
enter in Rotterdam approved the study, and all patients
ave written informed consent.
ardiac MRI protocol. A 1.5-T scanner with a dedicated
-element phased-array receiver coil was used for imaging
Signa CV/i, GE Medical systems, Milwaukee, Wisconsin).
ine cardiac MRI was performed with a steady-state free-
recession technique (FIESTA). Pulse sequence details have 3een published previously (8). To cover the entire ventricle, 10
o 12 short-axis slices were planned in the 4- and 2-chamber
iews (gap 2 mm). Dobutamine was infused at 5 and 10
g/kg/min for 5 min at each dosage with an intravenous
atheter, which was placed in the antecubital vein. Functional
maging was repeated during dobutamine infusion with the
ame long-axis imaging planes as at rest; for the short-axis only
slices were acquired. The 3 slices covered the basal, mid, and
pical parts of the LV. During the test the patients were
onitored with electrocardiographic leads for rhythm control,
nd blood pressure was measured at every 3-min interval.
riteria for ending the dobutamine-cardiac MRI examination
ere: 1) development of a new wall motion abnormality; 2) fall
f systolic blood pressure of 40 mm Hg; 3) marked hyper-
ension 240/120 mm Hg; 4)
evere chest pain; 5) ventricular
rrhythmias or new atrial arrhyth-
ias; or 6) intolerable side effects
f dobutamine.
Delayed enhancement (DE)
ardiac MRI was performed 20
in after infusion of gadolinium-
iethyltriaminepentaacetic acid
0.2 mmol/kg intravenously,
agnevist, Schering, Germany).
gated breath-hold T1-inversion
ecovery gradient-echo sequence
as used as described previously
8). The slice locations of the
elayed enhanced images were
opied from the cine-images.
eﬁnitions and data analysis. All
onventional angiograms before
CI were evaluated by 2 observ-
rs, and lesions were scored visu-
lly (50%, 50% to 99%, or
00%). A stenosis was considered
ignificant if the diameter stenosis
as 50%. Multivessel disease
as defined as the presence of a
ignificant lesion in at least 2 epicardial vessels in different
erfusion territories. A chronic total occlusion (CTO) was
lassified as a complete occlusion for more than 3 months as
btained from either the clinical history of prolonged anginal
hest pain or the date of the diagnostic angiogram before PCI.
evascularization was defined as complete when all significant
tenoses defined on conventional angiogram were successfully
reated. Revascularization was defined as incomplete when not
ll significant lesions but at least 1 was successfully treated.
evascularization was defined as unsuccessful when all signif-
cant lesions remained untreated. All cardiac magnetic reso-
ance images were transferred to a Microsoft Windows-based
ersonal computer for analysis with CAAS-MRV (version
Abbreviations
and Acronyms
ANOVA  analysis of
variance
AUC  area under the
receiver-operator
characteristic curve
CTO  chronic total
coronary occlusion
DE  delayed enhancement
DES  drug-eluting stent(s)
EF  ejection fraction
LV  left
ventricle/ventricular
LVEF  left ventricular
ejection fraction
MRI  magnetic resonance
imaging
NYHA  New York Heart
Association
PCI  percutaneous
coronary intervention
TEI  transmural extent
of infarction.2.1, Pie Medical Imaging, Maastricht, the Netherlands).
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394his software uses the additional information of the long-axis
o limit the extent of volumes at the base and apex of the heart.
he EF was determined by subtracting end-systolic endocar-
ial volume from the end-diastolic endocardial volume and
ividing this number by the end-diastolic endocardial volume.
apillary muscles and trabeculations were considered as being
art of the blood pool volume. A 17-segment model, excluding
he apex, was used to analyze the myocardial wall in each
atient. The LV segments were determined, according to the
lace of the stenosis and left or right dominance, as being
erfused by a vessel with a significant lesion or a vessel with a
onsignificant lesion (9). Segmental wall-thickening was de-
ned as a percentage increase of LV wall thickness during
ystole compared with diastole. We studied the effect of
evascularization on global function and regional function. To
tudy the effect of revascularization on regional myocardial
unction, segments in the perfusion territory of a significant
esion (related to anatomy on conventional angiogram) were
nalyzed. Myocardial segments were considered dysfunctional
f wall thickening was 45% (10,11). Two viability indexes
ere evaluated before revascularization: 1) quantitative con-
ractile reserve during dobutamine-cardiac MRI; and 2) trans-
ural extent of infarction (TEI), which was calculated by
ividing the hyper enhanced area by the total area in 16
egments and expressed as a percentage. The TEI was divided
nto 5 groups: 0%, 1% to 25%, 25% to 50%, 50% to 75%, and
75% infarct transmurality/segment, and segmental wall
hickening was quantified for each group. A cutoff value of
EI 25% was used to predict functional recovery after
evascularization (10,12,13). For quantitative contractile re-
erve during dobutamine-cardiac MRI a cutoff value of 7% was
sed (Kirschbaum MD, unpublished data that are under
eview, 2009). The percentage of dysfunctional but viable
egments/patient was defined as the sum of all dysfunctional
ut viable segments divided by the total number of segments (n
16). The angiograms and cardiac MRI data were analyzed in
random order with the investigator blinded to the clinical
nformation and the previous results.
iochemistry. Troponin T was measured 6 h after the proce-
ure. If troponin T was above the upper limit of normal (0.02
g/l) serial blood samples were taken every 6 h until maximum
roponin T was identified. A diagnosis of an enzymatic
eriprocedural infarction was made according to the guidelines
European Society of Cardiology/American College of Cardi-
logy/American Heart Association) if troponin T was 3
he upper limit of normal (14). Troponin T was quantified
ith Electro Chemi Luminescence Immuno Assay (ECLIA)
n an Elecsys type 2010 (Roche Diagnostics, Almere, the
etherlands).
tatistical analysis. Continuous data are expressed as mean
alue  1 SD, whereas dichotomous data are expressed as
umbers and percentages. Differences in baseline characteris-
ics among patients undergoing complete, incomplete, or
nsuccessful revascularization were evaluated with chi-squareests, Fisher exact tests, 1-way analysis of variance (ANOVA),
r Kruskal-Wallis test where appropriate. The number of
egments/patient perfused by a significant lesion was tested
ith 1-way ANOVA. Post hoc analysis was performed with
onferroni correction. The changes in left ventricular ejection
raction (LVEF) and volumes within each group were tested
ith paired Student t test. The change in global functional
arameters among groups was tested with ANOVA or the
npaired Student t test. The relationship between the amount
f viability/patient and the change in LVEF was analyzed with
inear regression analysis. We present the observed area under
he receiver-operator characteristic curves (AUC) for both
redictors. Differences in sensitivity and specificity between
ontrasting dobutamine-cardiac MRI and DE-cardiac MRI
ere evaluated by McNemar tests with exact methods. All tests
ere performed 2-sided, and a p value of 0.05 was consid-
red statistically significant. All analyses were performed with
PSS version 15.0.1 (SPSS, Inc., Chicago, Illinois).
esults
atient population. Between June 2006 and January 2008,
18 patients who met the inclusion criteria were prospec-
ively selected, of which 28 refused to participate. Of the 90
Figure 1. Flow Diagram of Patient Recruitment
Flow diagram of patient recruitment according to the Standards for Report-
ing of Diagnostic Accuracy statement. CMR  cardiac magnetic resonance
imaging.
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395atients that were included, 71 completed the study proto-
ol. Inclusion flow chart is presented in Figure 1. The mean
ime interval between baseline cardiac MRI and PCI was
6  36 days; clinical evidence of myocardial infarction did
ot occur during this time interval. In 71 patients a second
ardiac MRI scan was repeated at a mean of 7  1 month
fter PCI. All treated patients received drug-eluting stents
DES). Baseline patient characteristics are presented in
able 1. Thirty-four patients underwent complete revascu-
arization by PCI. The left anterior descending artery was
reated in 34 patients, left circumflex artery was treated in 23
atients, right coronary artery was treated in 18 patients, the
ain stem was treated in 3 patients, first diagonal branch
Table 1. Baseline Patient Characteristics
Complete
(n  34
Age (yrs) 62 9
Men 28 (82)
Previous MI 16 (47)
MI on DE-CMR 29 (85)
Previous PCI 6 (18)
Risk factors for coronary artery disease
Smoking 6 (18)
Diabetes mellitus 6 (18)
Hypertension 14 (41)
Hypercholesterolemia 28 (82)
Family history 17 (50)
Medications
ACE inhibitor 14 (41)
Beta-blocker 30 (88)
Statin 33 (97)
ASA 33 (97)
Baseline ejection fraction (%) 46 1
Baseline end-systolic volume index (ml/m2) 56 3
Infarct size on DE-CMR (g) 24 2
2-vessel disease on CAG 25 (74)
Vessel with stenosis 50%
LAD 34 (38)
LCX 23 (26)
RCA 18 (20)
Main stem 3 (3)
Intermediate branch 0
MO 3 (3)
Diagonal 1 6 (7)
Diagonal 2 2 (2)
Total 89
Signiﬁcant lesions/patient 2.6
Chronic total occlusion 20 (59)
Syntax score 22.2 9
Values are presented as n (%) or mean SD.
ACE  angiotensin-converting enzyme; ASA  acetylsalicylic acid
magnetic resonance imaging; LAD  left anterior descending artery
obtuses; PCI percutaneous coronary intervention; RCA right coroas treated in 6 patients, second diagonal branch was wreated in 2 patients, and the marginal obtuses were treated
n 3 patients. A total of 89 vessels and 94 lesions underwent
CI with DES implantation. An average of 1.9 DES/vessel
nd 4.1 DES/patient were implanted with an average stent
ength of 21.3 mm/patient. New York Heart Association
NYHA) functional classification improved from 2.6  1.1
efore revascularization to 1.1  0.4 at 6-month follow-up.
In patients with incomplete revascularization (n  22),
eft anterior descending artery was treated in 8 patients, the
rst diagonal branch was treated in 1 patient, the left
ircumflex artery was treated in 4 patients, the marginal
btuses were treated in 1 patient, and the right coronary
rtery was treated in 10 patients. An average of 2.8 DES
Incomplete PCI
(n  22)
Unsuccessful PCI
(n  15) p Value
64 10 62 9 0.54
14 (64) 12 (80) 0.57
9 (41) 6 (40) 0.77
17 (77) 12 (80) 0.71
6 (22) 7 (47) 0.10
4 (18) 3 (20) 0.86
2 (9) 2 (13) 0.87
10 (45) 7 (47) 0.86
14 (64) 15 (100) 0.50
9 (41) 9 (60) 0.52
10 (45) 7 (47) 0.86
20 (91) 15 (100) 0.47
20 (91) 14 (93) 0.54
20 (91) 15 (100) 0.44
49 11 49 13 0.51
52 23 47 23 0.10
19 22 25 21 0.30
15 (69) 10 (67) 0.56
18 (38) 9 (25) 0.04
10 (21) 6 (17) 0.23
14 (29) 10 (28) 0.98
0 0 0.30
2 (4) 2 (6) 0.64
3 (6) 3 (8) 0.60
1 (2) 4 (11) 0.11
0 0 0.70
48 36
2.2 2.4 0.17
19 (86) 10 (67) 0.04
22.0 13.0 24.0 14.1 0.90
 coronary angiography; DE-CMR  delayed enhancement cardiac
left circumflex artery; MI  myocardial infarction; MO  marginal
ery.PCI
)
2
4
1
.6
; CAG
; LCX ere implanted/vessel with an average stent length of 22.1
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396m. The NYHA functional classification was 2.6  0.7
efore and changed to 1.4  0.5 at 6-month follow-up. In
5 patients, PCI was not successful, mainly due to the
resence of a chronic total coronary occlusion, and in some
atients CABG was already rejected as a treatment option,
ue to comorbidity; these patients were only medically
reated. The NYHA functional classification changed from
.8  0.8 at baseline and changed to 2.1  1.1 at 6-month
ollow-up. Administration of low-dose dobutamine during
ardiac MRI was well-tolerated by all patients; no serious
ide effects occurred. All patients with DE showed a
istribution pattern extending from the endocardium, typ-
cal for ischemic heart disease.
yocardial injury by DE-cardiac MRI and serum markers.
elayed enhancement cardiac MRI before PCI showed
re-existing myocardial damage in 85% (29 of 34) of the
atients that underwent complete revascularization, in 77%
17 of 22) of the patients with incomplete revascularization,
nd in 87% (13 of 15) of the patients with an unsuccessful
evascularization (p  0.97). Mean infarct mass at baseline
as 24  21 g in patients that underwent complete
evascularization, 19  22 g in patients with incomplete
evascularization, and 25  21 g in patients with unsuccess-
ul revascularization (p  0.70). The number of dysfunc-
ional segments (TEI 25%) and dobutamine responsive
egments/patient showed no significant difference for the 3
roups (Table 2).
Troponin levels after procedure were elevated in 10
atients that underwent complete revascularization in which
ew patterns of late enhancement appeared in 3 patients and
n 5 patients that underwent incomplete revascularization;
one of these patients developed new patterns of DE. For
he 3 patients in the complete revascularization group that
eveloped new patterns of DE, maximum troponin levels
ere 0.65, 0.43, and 0.06 g/l, and corresponding new
nfarct masses on DE were 6.7, 9.4, and 2.0 g, respectively.
n the 3 patients with new DE, the average myocardial infarct
ass changed from 11 g to 19 g. The change in infarct mass in
hese 3 patients did not change the total infarct size in the
omplete revascularization group (23.6  21.7 g to 23.9 
2.6 g). In patients without successful revascularization,
roponin levels were elevated in 3 patients, and only 1
atient developed a new infarct pattern on DE-cardiac
Table 2. Number of Segments/Patient Perfused by a
Complete P
Dysfunctional segments/patient* 5.73 2.4
TEI 25% segments/patient 3.03 1.8
Dobutamine responsive segments/patient 3.29 1.6
Values are presented as mean SD. *Segmental wall thickening45
TEI transmural extent of infarction; other abbreviations as in TablRI. The new infarct mass was 2 g. Total infarct mass didot change in these patients (22.0  22.2 g to 20.6 
2.3 g).
V function and volumes. Pre-PCI cardiac function did not
iffer significantly among the 3 groups (46  12% vs. 49 
1% vs. 49  13%, p  0.51). In patients with complete
evascularization by PCI, mean EF improved significantly
rom 46  12% before revascularization to 51  13% (p 
.0001) at 6-month follow-up. The EF did not change
ignificantly in patients after incomplete (49 11% to 49
0%; p  0.88) and without successful revascularization
49  13% to 47  13%; p  0.11). More detailed
nformation is presented in Table 3.
Table 3. Functional Data at Baseline and at 6-Month Follow-Up on
Left Ventricular Function
Complete PCI
(n  34)
Incomplete PCI
(n  22)
Unsuccessful PCI
(n  15)
EF (%)
Baseline 46 12 49 11 49 13
6 months 51 13 49 10 47 13
∆EF 4 5 1 5 2 4
p Value 0.0001 0.88 0.11
ESVi (ml/m2)
Baseline 56 34 52 23 47 23
6 months 51 37 48 25 46 23
∆ESVi 5 8 4 10 1 5
p Value 0.0005 0.70 0.58
EDVi (ml/m2)
Baseline 99 36 98 22 87 24
6 months 96 37 91 29 82 24
∆EDVi 3 10 7 15 5 9
p Value 0.11 0.74 0.07
Cardiac output
Baseline 5.5 1.0 6.1 1.2 5.7 1.2
6 months 6.0 1.3 6.0 1.4 5.1 1.1
∆CO 0.5 1.2 0.2 1.0 0.7 1.1
p Value 0.02 0.79 0.10
SV
Baseline 84 16 96 21 82 18
6 months 88 19 90 22 76 14
∆SV 4 15 6 17 6 15
p Value 0.13 0.29 0.16
Values are presented as mean SD.
CO  cardiac output; EDVi  end-diastolic volume index; EF  ejection fraction; ESVi 
ficant Lesion According to the Different Groups
Incomplete PCI Unsuccessful PCI p Value
4.52 1.12 5.14 2.95 0.38
2.57 1.75 1.86 1.35 0.12
2.65 1.62 3.33 2.42 0.45
t at baseline.Signi
CI
1
3
8
% at resend-systolic volume index; SV stroke volume; other abbreviations as in Table 1.
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397The improvement in EF and cardiac output in the group
hat underwent complete revascularization was significantly
igher as compared with patients that underwent incom-
lete or unsuccessful revascularization (Table 4). In patients
ith complete revascularization the change in global param-
ters was not influenced by positive troponin level after PCI
r whether a CTO was treated. There was a trend toward a
reater improvement in EF in patients with a baseline
nfarct size24 g versus patients with an infarct size of24 g
5.4  4.4% vs. 2.8  5.1%; p  0.10) (Table 4).
lobal contractile function and the predictive value of car-
iac MRI. The change in EF was linearly related to the
xtent of the LV that was dysfunctional but viable before PCI
or TEI 25% (r  0.64; p  0.0001) (Fig. 2A) and for
ontractile reserve 7% (r  0.67; p  0.0001) (Fig. 2B).
According to the linear regression line for TEI, 4%
mprovement in EF corresponded to 25% of the LV that
as dysfunctional but viable, which are 4 segments before
evascularization. The AUC for DE-cardiac MRI to predict
mprovement in EF was 0.84 (95% confidence interval: 0.74
o 0.95; p  0.0001). For dobutamine-cardiac MRI, 3
ysfunctional but viable segments/ventricle were required to
chieve an improvement in EF 4%. The AUC for
obutamine-cardiac MRI to predict improvement in EF
as 0.91 (95% confidence interval: 0.82 to 0.99; p 
.0001). Dobutamine-cardiac MRI had a significant higher
ensitivity (100% vs. 70%; p  0.0001), and specificity was
ot different (75% vs. 77%; p  0.80) as compared with
E-cardiac MRI. Sensitivity, specificity, positive predictive
alue, and negative predictive value for both viability pa-
ameters were presented in Table 5.
egional contractile function. Segments were stratified ac-
ording to the presence or absence of viability in the
Table 4. Functional Data According to Different Subgroups
n EF
Complete revascularization 34 4.2 4.9
Incomplete revascularization 22 0.7 6.1
Unsuccessful revascularization 15 1.9 4.1*
Complete revascularization
Without CTO treatment 14 3.6 5.9
With CTO treatment 20 4.4 4.2
p Value 0.77
Complete revascularization
Infarct size 24 g 17 5.4 4.4
Infarct size 24 g 17 2.8 5.1
p Value 0.10
Complete revascularization
No enzymatic infarction 24 4.7 4.5
Enzymatic infarction 10 2.9 6.2
p Value 0.55
Values are presented as mean SD. *p 0.05 as compared with the group that underwent complCTO chronic total occlusion; other abbreviations as in Table 3.erfusion territory of vessels with significant lesions. Seg-
ental wall thickening improved significantly in patients
ho underwent PCI if contractile reserve (positive change
n segmental wall thickening 7%) was present or if TEI
as25%. Segmental wall thickening remained unchanged
n patients with unsuccessful PCI regardless, if viable tissue
as present (Fig. 3).
iscussion
o study the effect of multivessel PCI on depressed EF we
sed cardiac MRI, because it is currently accepted as the
tandard of reference to determine LV function (15). In
ddition we used both the TEI with DE-cardiac MRI and
obutamine stress cardiac MRI as potential predictors of
ecovery of myocardial function after PCI (12,16,17). Pre-
nd post-procedural DE-cardiac MRI can also detect new
eri-procedural myocardial infarction during PCI that
ight outweigh the potential positive effect on myocardial
unction.
In our study we demonstrated in patients with dysfunc-
ional myocardium referred for PCI for multivessel coronary
rtery disease that complete revascularization by PCI im-
roved EF, whereas incomplete revascularization and unsuc-
essful revascularization did not improve EF. The extent of
ysfunctional but viable myocardium/ventricle was linearly
elated to improvement in EF after PCI. This was reflected by
he improvement in EF in patients with complete PCI in
hom more dysfunctional but viable segments were revascu-
arized than in patients with incomplete or unsuccessful PCI.
he change in EF could be predicted by pre-treatment cardiac
RI where dobutamine-cardiac MRI had a higher diagnostic
erformance than the more widely used DE-cardiac MRI.
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398verall LV function. The magnitude of change of EF of 4%
n patients that underwent complete PCI in the present
tudy was relatively small but in line with previously
eported data about the effect of CABG on LV function
here an increase in EF of 4% to 5% was also reported
18,19). Several established clinical therapies for ischemic
eart failure with a demonstrated significant impact on
rognosis, such as angiotensin-converting enzyme inhibitor
r beta-blocker therapy, are associated with similar im-
rovements in LVEF (20).
The EF did not change in patients with multivessel
isease followed by incomplete PCI, although segments in
he perfusion territory of the significant lesion in patients
ith incomplete PCI were dysfunctional and viable, but
pparently remaining nontreated lesions subserving dys-
unctional segments might have diluted any positive
ffect. Not unexpectedly, an unsuccessful attempt did not
Figure 2. Prediction of Change in Ejection Fraction
The change in left ventricular ejection fraction was related to the extent of
dysfunctional but viable myocardium before revascularization with delayed
enhancement cardiac magnetic resonance imaging (A) and with dobu-
tamine cardiac magnetic resonance imaging (B). Solid circles  complete
revascularization; open circles  incomplete revascularization. TEI  trans-
mural extent of infarction.mprove EF. The significant increase in EF in patientshat underwent complete revascularization might be a
eason for the beneficial effect of complete revasculariza-
ion on survival (6,7).
The PCI procedure might be associated with peri-
rocedural myocardial infarction, which might offset the
otential improvement of successful revascularization of
ysfunctional but viable myocardial tissue. To account for
his effect, we performed DE-cardiac MRI before and after
he procedure to detect the occurrence of procedure-related
yocardial infarctions. Only 3 patients with successful,
omplete PCI developed a peri-procedural infarction on
E-cardiac MRI; in 2 of these patients EF improved, and
n the other patient EF remained the same. In the patient
roup with an unsuccessful attempt, 1 patient developed a
eri-procedural myocardial infarction of 2 g, which is small
ecause the mean infarct mass in these patients was 25 g. In
atients with incomplete PCI no peri-procedural infarcts
ere detected. Therefore we can conclude that the lack of
hange in EF in these last 2 patient groups was not
nfluenced by peri-procedural infarctions.
The improvement in EF in the present study was linearly
elated to the amount of dysfunctional but viable myocar-
ium before revascularization (r  0.64, p  0.001 for
E-cardiac MRI; and r  0.67, p  0.001 for dobu-
amine), as was also shown by previously reported data by
im et al. (12). They reported in a cohort of 41 patients
ndergoing revascularization by either PCI (n  14) or
ABG (n  27) that an increasing extent of dysfunctional
ut viable myocardium before revascularization correlated
ith greater improvements in EF after revascularization
r  0.70; p  0.001).
rediction of recovery of EF. Previous studies using echo-
ardiography or nuclear imaging have shown that improve-
ent of EF after revascularization can be predicted with a
ensitivity of 57% to 84% and a specificity of 53% to 73%
21). In our study we demonstrated that the predictive
ower of dobutamine-cardiac MRI was higher, with a
ensitivity of 100% and a specificity of 75%. However, the
ensitivity with DE-cardiac MRI was lower (70%), and
pecificity was 77%. Several reasons might explain why
obutamine cardiac MRI had a higher diagnostic perfor-
ance than DE-cardiac MRI. Dobutamine stress testing is
functional parameter; the positive inotropic effects of
Table 5. Diagnostic Accuracy for the Prediction of Improvement in
Global Function
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
TEI 25% 70 (50–86) 77 (58–89) 70 (47–86) 77 (58–90)
Contractile reserve
(7%)
100 (81–100) 75 (55–89) 74 (53–88) 100 (81–100)
Values are presented as means (95% confidence intervals).
NPV negative predictive value; PPV positive predictive value; TEI transmural extent ofinfarction.
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399obutamine are a measure of functionality that mimics the
otential effects of revascularization by improving contrac-
ile function in hypoperfused myocardium even in the
bsence of an increase in blood flow (22–24).
Delayed enhancement cardiac MRI is an anatomic pa-
ameter that accurately delineates the extent of infarction
hat will not improve after revascularization (25) but does
ot provide information on the extent and the functional
tate of the surrounding viable myocardium. The TEI is a
elative value that omits the thickness of a segment and
ight therefore miss important information that is relevant
or accurate prediction of recovery of function after revas-
ularization therapy (13).
tudy limitations. The number of patients included in this
tudy was relatively small; nevertheless, with cardiac MRI as
he gold standard for the serial assessment of cardiac
unction (26,27), we were able to demonstrate a significant
mprovement in EF. Baseline EF tended to be lower for the
roup that underwent complete revascularization as com-
ared with the other 2 groups, which in theory might have
nfluenced outcome results positively, although our results
or PCI are in line with results published for CABG
18,19).
The patients in the present study had a moderately
educed EF. The results might not be applicable to patients
ith a severely reduced EF, because in these patients more
onviable segments might be present; however, cardiac
RI is able to detect the presence of viability that is
ndependent of the EF. Our results might have been
ompromised by the occurrence of in-stent restenosis,
ecause we did not perform late invasive coronary angiog-
aphy. However, the likelihood of in-stent restenosis is low
Figure 3. Segmental Wall Thickening for Dysfunctional Segments in the Pe
Nonviable Segments
Improvement in segmental wall thickening was related to the presence of viab
(PCI). Solid bars  before PCI; open bars  6 months after revascularization.fter DES implantation, and the patients that underwentomplete revascularization were all symptom-free at
ollow-up (28).
onclusions
eft ventricular EF improves after complete revasculariza-
ion and does not change after incomplete or unsuccessful
evascularization in patients with multivessel coronary artery
isease and dysfunctional myocardium. The change in EF
fter PCI could be predicted with pre-treatment cardiac
RI, where dobutamine-cardiac MRI had a higher diag-
ostic performance than DE-cardiac MRI.
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